Morphine/lidocaine topical spray - EpiCept

Drug Profile

Morphine/lidocaine topical spray - EpiCept

Alternative Names: EpiCept™MP/DP; EpiCept™MS Spray; Lidocaine/morphine; LidoPAINMP/DP; MS Spray

Latest Information Update: 17 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Memorial Sloan-Kettering Cancer Center
  • Developer EpiCept Corporation
  • Class
  • Mechanism of Action Opioid receptor agonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 30 Jun 2004 Phase-II clinical trials in Pain in USA (Topical)
  • 31 Aug 2000 Phase-I clinical trials in Pain in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top